SOPHiA GENETICS (SOPH) Competitors $3.04 -0.25 (-7.60%) Closing price 07/2/2025 04:00 PM EasternExtended Trading$3.23 +0.19 (+6.25%) As of 07/2/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SOPH vs. COGT, CRMD, IMNM, CMRX, CDMO, SNDX, AVXL, SION, QURE, and AVBPShould you be buying SOPHiA GENETICS stock or one of its competitors? The main competitors of SOPHiA GENETICS include Cogent Biosciences (COGT), CorMedix (CRMD), Immunome (IMNM), Chimerix (CMRX), Avid Bioservices (CDMO), Syndax Pharmaceuticals (SNDX), Anavex Life Sciences (AVXL), Sionna Therapeutics (SION), uniQure (QURE), and ArriVent BioPharma (AVBP). These companies are all part of the "pharmaceutical products" industry. SOPHiA GENETICS vs. Its Competitors Cogent Biosciences CorMedix Immunome Chimerix Avid Bioservices Syndax Pharmaceuticals Anavex Life Sciences Sionna Therapeutics uniQure ArriVent BioPharma SOPHiA GENETICS (NASDAQ:SOPH) and Cogent Biosciences (NASDAQ:COGT) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, valuation, institutional ownership, media sentiment and earnings. Does the media refer more to SOPH or COGT? In the previous week, Cogent Biosciences had 7 more articles in the media than SOPHiA GENETICS. MarketBeat recorded 7 mentions for Cogent Biosciences and 0 mentions for SOPHiA GENETICS. Cogent Biosciences' average media sentiment score of 1.01 beat SOPHiA GENETICS's score of 1.00 indicating that Cogent Biosciences is being referred to more favorably in the news media. Company Overall Sentiment SOPHiA GENETICS Positive Cogent Biosciences Positive Do insiders and institutionals hold more shares of SOPH or COGT? 31.6% of SOPHiA GENETICS shares are owned by institutional investors. 4.9% of SOPHiA GENETICS shares are owned by company insiders. Comparatively, 7.3% of Cogent Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has more volatility & risk, SOPH or COGT? SOPHiA GENETICS has a beta of 1, suggesting that its share price has a similar volatility profile to the S&P 500.Comparatively, Cogent Biosciences has a beta of 1.88, suggesting that its share price is 88% more volatile than the S&P 500. Is SOPH or COGT more profitable? Cogent Biosciences has a net margin of 0.00% compared to SOPHiA GENETICS's net margin of -98.51%. SOPHiA GENETICS's return on equity of -63.47% beat Cogent Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets SOPHiA GENETICS-98.51% -63.47% -40.06% Cogent Biosciences N/A -149.79%-75.61% Do analysts rate SOPH or COGT? SOPHiA GENETICS presently has a consensus price target of $7.00, suggesting a potential upside of 130.26%. Cogent Biosciences has a consensus price target of $14.43, suggesting a potential upside of 94.72%. Given SOPHiA GENETICS's higher possible upside, equities analysts plainly believe SOPHiA GENETICS is more favorable than Cogent Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SOPHiA GENETICS 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67Cogent Biosciences 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.75 Which has higher earnings and valuation, SOPH or COGT? SOPHiA GENETICS has higher revenue and earnings than Cogent Biosciences. Cogent Biosciences is trading at a lower price-to-earnings ratio than SOPHiA GENETICS, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSOPHiA GENETICS$65.17M3.11-$62.49M-$1.00-3.04Cogent BiosciencesN/AN/A-$255.86M-$1.84-4.03 SummarySOPHiA GENETICS and Cogent Biosciences tied by winning 8 of the 16 factors compared between the two stocks. Get SOPHiA GENETICS News Delivered to You Automatically Sign up to receive the latest news and ratings for SOPH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SOPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SOPH vs. The Competition Export to ExcelMetricSOPHiA GENETICSMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$219.40M$1.99B$5.54B$8.87BDividend YieldN/AN/A5.39%4.10%P/E Ratio-3.0433.4026.1919.90Price / Sales3.1115.92414.04113.66Price / CashN/A55.6636.1356.90Price / Book2.058.588.025.38Net Income-$62.49M-$62.39M$3.15B$248.50M7 Day Performance-1.94%0.44%1.48%2.06%1 Month Performance0.33%2.49%3.67%4.86%1 Year Performance-34.76%3.30%34.68%20.24% SOPHiA GENETICS Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SOPHSOPHiA GENETICS2.834 of 5 stars$3.04-7.6%$7.00+130.3%-33.8%$219.40M$65.17M-3.04520Positive NewsCOGTCogent Biosciences2.7428 of 5 stars$7.13-0.6%$14.43+102.3%-10.1%$809.55MN/A-3.8680Positive NewsAnalyst ForecastAnalyst RevisionCRMDCorMedix2.3707 of 5 stars$11.97-2.8%$17.14+43.2%+181.3%$809.09M$43.47M54.2330Analyst ForecastAnalyst RevisionIMNMImmunome2.4739 of 5 stars$9.21-1.0%$23.33+153.5%-26.2%$801.88M$9.04M-2.9040Positive NewsCMRXChimerix0.6762 of 5 stars$8.54flat$8.53-0.1%N/A$801.09M$212K-9.0990CDMOAvid Bioservices0.9274 of 5 stars$12.50+0.1%$12.25-2.0%+86.5%$799.18M$139.91M-5.23320News CoverageHigh Trading VolumeSNDXSyndax Pharmaceuticals3.1352 of 5 stars$9.26-1.2%$35.80+286.6%-56.4%$795.02M$23.68M-2.39110Positive NewsAVXLAnavex Life Sciences3.803 of 5 stars$9.26+0.4%$44.00+375.3%+155.9%$791.38MN/A-16.8540News CoveragePositive NewsSIONSionna TherapeuticsN/A$17.35+9.5%$38.50+121.9%N/A$765.55MN/A0.0035News CoveragePositive NewsInsider TradeGap UpQUREuniQure2.205 of 5 stars$14.02+0.6%$37.82+169.7%+256.1%$765.28M$27.12M-3.18500News CoverageAVBPArriVent BioPharma1.7477 of 5 stars$21.82+0.2%$40.00+83.3%+14.6%$743.90MN/A-5.7740Gap Down Related Companies and Tools Related Companies COGT Alternatives CRMD Alternatives IMNM Alternatives CMRX Alternatives CDMO Alternatives SNDX Alternatives AVXL Alternatives SION Alternatives QURE Alternatives AVBP Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SOPH) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SOPHiA GENETICS SA Please log in to your account or sign up in order to add this asset to your watchlist. Share SOPHiA GENETICS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SOPH Stock Alerts